Podcast ist wieder da.

Renewables overtake coal as world's biggest source of electricity. 🧪 www.bbc.co.uk/news/article...

WE MAY HAVE ALL THE DRUGS WE NEED. All you ever wanted to know about REPO4EU's Drug Repurposing and Network and Systems Medicine innovation, but never dared to ask. Interview by Artur Olesch. www.icthealth.org/news/how-ai-...

#RExPO25 💊 3 days in 30 seconds! A huge thanks to everyone who joined us in Barcelona for the 4th edition of our international conference on Systems Medicine, AI & Drug Repurposing. Check all talks and posters abstracts via @scienceopen.bsky.social ⤵️ drugrepocentral.scienceopen.com/search#%7B%2...

REPO4EU partners in action 🦾 The @cosybio-uhh.bsky.social team recently hosted a workshop at @uni-hamburg.de to validate the AI-powered #DrugRepurposing workflows being developed by researchers from @daisybio.de, @univie.ac.at and @upm.es Learn more about our mission 💊 repo4.eu/the-platform/

How can we build a healthcare system that effectively cures diseases instead of merely treating symptoms? 💊 Come and find out at #RExPO25! Join us in Barcelona or online on 24-26 September 👉 repo4.eu/rexpo25/ #EUfunded #DrugRepurposing #FutureOfMedicine #Healthcare #Medicine #PharmaInnovation

'Can we Make Health Economic Decision Models as Simple as Possible, but Not Simpler? Introducing the SMART tool' - an @repo4eu.bsky.social DrugRxiv #Preprint open for review on #ScienceOpen: 🔗 drugrepocentral.scienceopen.com/hosted-docum... #HealthEconomics #OpenAccess #Research

To make #RExPO25 as globally inclusive as the challenges we aim to tackle, we offer a limited number of reduced-rate tickets for online participation. If this sounds relevant to you, check all the details on our website 👉 repo4.eu/rexpo25/ #AcademicSky #Medicine #Healthcare #DrugRepurposing

#RExPO25 Conference abstract: 'From systems to single cells: Advancing network medicine in neurological disorders' ➡ drugrepocentral.scienceopen.com/hosted-docum... ✍️ Presented by Andrea Álvarez Pérez, PhD Student at @upm.es Join us in Barcelona or online on 24-26 September 💊 repo4.eu/rexpo25/

#RExPO25 Speakers | Session 4: 🟣 Ranjita Shegokar (DiHeSys) 🟣 Eduardo Díaz (FABRX AI) 🟣 Elisabetta Vaudano (‪@ihieurope.bsky.social‬) 🟣 Lee Lancashire (EveryCure) 🟣 Merel Kimman (Maastricht UMC+) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen... 🇪🇺 #EUfunded #DrugRepurposing

To learn more about SMART, read the paper published on PharmacoEconomics Journal: 'Can We Make Health Economic Decision Models as Simple as Possible, But Not Simpler? Introducing SMART tool' ➡️ link.springer.com/article/10.1... @manuelajoore.bsky.social @sabine-e-grimm.bsky.social

A team of #REPO4EU researchers from @maastrichtumc.bsky.social have developed a new tool to make decision models more accessible in early-stage or data-limited healthcare research. But how will it benefit #DrugRepurposing researchers? Read the full story to find out 👉 repo4.eu/2025/08/26/r...

#RExPO25 Speakers | S5: Network Medicine Alliance 🟣 Joe Loscalzo, Michelle Li & Kathryn T. Hall (@harvardmed.bsky.social) 🟣 Paola Paci (Sapienza U. Roma) 🟣 Farzaneh Firoozbakht (@cosybio-uhh.bsky.social) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen... 🇪🇺 #EUfunded #DrugRepurposing

#RExPO25 Speakers | S6: Translating to the global market 🟣 Edward Allera & Matthew Fedowitz (Buchanan Ingersoll & Rooney PC) 🟣 David Cavalla (Numedicus) 🟣 Anja Schiel (Norwegian Medical Products Agency) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen... 🇪🇺 #EUfunded #DrugRepurposing

And for those who enjoyed our tutorial on network medicine and drug repurposing: if you are spontaneous, consider joining us for the RExPO conference organized by @repo4eu.bsky.social repo4.eu/rexpo25/ later this month.

There's still time to grab a ticket and join #RExPO25 in Barcelona or online! We hope to welcome known and new faces from across the entire healthcare ecosystem... including journalists, early-stage researchers and patient representatives. Check out all the details on our website: repo4.eu/rexpo25/

Every year we think about new ways to make RExPO bigger and better 💊 Besides welcoming top specialists from all over the world and expanding the list of topics, for #RExPO25 we'll count on Artur Olesch, Digital Healthcare Journalist, as Programme Moderator! youtu.be/F9eP5B4m6M0?...

📣 New Article from Network and Systems Medicine on #ScienceOpen! 🆕📄 'Identification of Transcriptional Regulators Using a Combined Disease Module Identification and Prize-Collecting Steiner Tree Approach' @repo4eu.bsky.social #NetworkMedicine #Bioinformatics #TranscriptionFactors

#RExPO25 Speakers | S10: REPO4EU's #DrugRepurposing Platform 🟣 Chloé Bucheron (@univie.ac.at) 🟣 Frauke Herbst (Eurofins Discovery) 🟣 Hermann Mucke (H.M. Pharma) 🟣 Balázs Orbán (@egnosis.bsky.social) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen...

#RExPO25 Speakers | S11: Accessibility for patient benefit 🟣 Sibylle Reichert (@aim-healthcare.bsky.social) 🟣 Jocelijn Stokx (CM/MC) 🟣 Nerea Blanqué (Alira Health) 🟣 Teebah Abu-Zahra (Maastricht UMC+) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen...

#RExPO25 Speakers | S13: AI/ML in Systems Medicine & Drug Repurposing 🟣 Stefano Piotto (SoftMining) 🟣 Laura P. Cano (STALICLA) 🟣 Siqi Wei (@radboudumc.bsky.social) 🟣 Andrew Crouse (UAB Medicine) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen...

#RExPO25 Speakers | S14: The patient voice 🟣 Ana Sofia Carvalho (University of Porto) 🟣 François Houÿez (@eurordis.bsky.social) 🟣 Alain Geille (Euro-DyMA) 🟣 George Patrinos (Hellenic Pasteur Institute) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen...

Up now at @repo4eu.bsky.social #RExPO25: Merel Kimmen 'How can patient-based evidence support health technology assessment in mechanism-based drug repurposing? ' Read the abstract on #ScienceOpen @scienceopen.bsky.social : drugrepocentral.scienceopen.com/hosted-docum...

Meet the #RExPO25 Honorary Lecturer 💊 Alfonso Valencia (@bsc-cns.bsky.social) We're honoured to welcome @alfonsovalencia.bsky.social to this year's conference! In his lecture, he'll reflect on advancing #Biomedicine through computing, networks & AI. Check the full agenda ➡️ repo4.eu/rexpo25/agen...

Important work by Ana Casas at #RExPO25 'An Integrative Systems Medicine Framework for Ischemic #Stroke: In Silico-Based Target Identification, Network Pharmacology, and Immune Mechanistic Redefinition' @scienceopen.bsky.social @repo4eu.bsky.social : drugrepocentral.scienceopen.com/hosted-docum...

#RExPO25 Speakers | S8: Mechanism-based repurposing around the globe 🟣 @hhhwschmidt.bsky.social (@maastrichtu.bsky.social) 🟣 Jens Habermann (@bbmrieric.bsky.social) 🟣 Johannes Beckers (INFRAFRONTIER) 🟣 Hugo Filipe (RePo-SUDOE) 🟣 Sona Vasudevan (Georgetown University) repo4.eu/rexpo25/agen...

#RExPO25 Speakers | S9: Hot topics & late-breaking abstracts 🟣 Michael Firgens (MF BIOTECH) 🟣 João Joaquim (Instituto Politécnico de Coimbra) 🟣 Jasmin Bahr (U. Hospital Essen) 🟣 Natalie Binder & Natasha Alwis (U. Melbourne) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen...

#RExPO25 Speakers | S7: AI/ML in #SystemsMedicine & #DrugRepurposing 🟣 @itisalist.bsky.social & Lisa Spindler (@daisybio.de) 🟣 Jan Baumbach & Fernando Delgado Chavez (@cosybio-uhh.bsky.social) Check the full conference agenda ⤵️ repo4.eu/rexpo25/agen... 🇪🇺 #EUfunded #DrugRepurposing

#RExPO25 Speaker Spotlight 💊 Anja Schiel, Senior Advisor for the Norwegian Medical Products Agency (NOMA) Find out more about her motivation for joining this year's #DrugRepurposing conference and why she encourages other HTAs and regulatory experts to attend 👇 youtu.be/LoIO9yijIOQ?...

Calling out #PhD students! If you're interested in how #DrugRepurposing can drive the #FutureOfMedicine, you shouldn't miss #RExPO25 💊 the conference presenting the latest advances in the fields of #NetworkMedicine & #HealthcareInnovation. Get your discounted ticket 👉 repo4.eu/rexpo25/

#RExPO25 Speakers | S1: Meeting unmet medical needs in cancer 🟣 Jelena Gnjatovic (FICAN West) 🟣 Prashant Changoer (@radboudumc.bsky.social) 🟣 @albertantolin.bsky.social (@idibell.bsky.social) 🟣 Ana Álvarez (RePo-SUDOE) Check the conference agenda ⤵️ repo4.eu/rexpo25/agen...

We’re honoured to introduce Buchanan Ingersoll & Rooney as official sponsor of #RExPO25 💊 Thank you for supporting the 4th international conference on Systems Medicine, AI and Drug Repurposing. Join us in Barcelona or online on 24-26 September 2025 👉 repo4.eu/rexpo25/

During a recent consortium trip to Romania, hosted by @egnosis.bsky.social, some of our partners were interviewed to talk about how we're advancing mechanism-based #DrugRepurposing globally 💊 Learn more about our mission: repo4.eu/the-platform/ @hhhwschmidt.bsky.social @sdawsonberlin.bsky.social

New study on #DrugRepurposing by REPO4EU researchers 💊 'Synergistic Network Pharmacology: Preclinical Validation & Clinical Safety in Acute Ischemic Stroke' ⤵️ www.ahajournals.org/doi/10.1161/... @neurologieessen.bsky.social @maastrichtu.bsky.social @cosybio-uhh.bsky.social @hhhwschmidt.bsky.social

What is #RExPO25 all about? Why are we hosting it in Barcelona? Who shouldn't miss it? Co-chairs @hhhwschmidt.bsky.social & Emre Guney explain what we can expect from this year's conference, and how it will foster interdisciplinary collaborations for #DrugRepurposing 👉 youtu.be/eqMjMwVWpnE?...

'DrugRxiv' is an open community resource for preprints from the field of #DrugRepurposing: drugrepocentral.scienceopen.com/collection/D...

The @repo4eu.bsky.social #OpenAccess Drug Repurposing journal aims to provide an interdisciplinary and cross-sectional overview of the fields of #Research and applied sciences that work together to make successful #DrugRepurposing projects a reality: drugrepocentral.scienceopen.com/collection/D...

'AI-Mind: Revolutionizing Personalized #Neurology Through Automated #Diagnostics and Advanced #Data Management' - an @repo4eu.bsky.social #DrugRepurposing article on #ScienceOpen: drugrepocentral.scienceopen.com/hosted-docum...

'Manhattan Projects for Preventive Medicine' - an @repo4eu.bsky.social #Research article #Preprint open for review on #ScienceOpen: drugrepocentral.scienceopen.com/hosted-docum...

SCIENCE AND ART… … are two wonderful passions to work in and I don’t know anyone who has perfectionated both areas so fascinating than Albert-Laszlo Barabasi.

To our American Trump friends from the German “heute-show”

Home improvement.

🔵 AI IN MEDICINE: NEXT LEVEL DeepSeek AI a groundbreaking open-source and low-cost large language model (LLM), is reshaping health care in China — and pointing the way for the world. 🚀n in hospitals.

RARE DISEASE CELL AND ANIMAL MODELS. @INFRAFRONTIER the fresh new European infrastructure and ERIC has rare diseases made one of their focus themes. www.infrafrontier.eu/date/infrafr...

THERE IS NO PARKINSONS‘S DISEASE; THERE IS NO ALZHEIMER‘S DISEASE … and so on. Almost all our current disease definitions simply describe symptoms in organs or are named after a doctor 🤦🏼. They are umbrella terms lacking any understanding of the underlying different causal molecular mechanisms.

Campact gewinnt gegen Meta. Oskar Lafontaine hatte auf Facebook die Falschbehauptung verbreitet, Campact werde von der Bundesregierung und George Soros finanziert. Meta ließ sie trotz unserer Meldung stehen – jetzt zwingt ein Gericht den Konzern zur Löschung.

Das ist Ah­med Mo­ha­med Odo­waa. Er ist einer der beiden Männer, die den Täter von Aschaffenburg verfolgt haben, bis die Polizei ihn festnehmen konnte. Dafür bekam er Dankesschreiben, von Söder und vom Innenministerium. Er muss Deutschland bis zum 8. Juli verlassen, sonst wird er abgeschoben.

Timely. open.spotify.com/track/649Zk1...